Mice with knockout of Tyk2 were more susceptible to xenograft tumor growth and metastasis of breast cancer 4T1 cells, and Tyk-/- mice also developed leukemia and lymphoma at an increased rate, both likely due to defective tumor immunosurveillance [42,43]. This evidence concerns the gene TYK2 and leukemia.